Aethlon Medical advances to final trial cohort after safety review

March 24, 2026 8:01 AM

Aethlon Medical, Inc. (NASDAQ: AEMD) announced that an independent Data Safety Monitoring Board has approved advancement to the third and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found